OCTAGON CAPITAL ADVISORS LP – Apellis Pharmaceuticals, Inc. Transaction History
OCTAGON CAPITAL ADVISORS LP portfolio value:
$170.95M
portfolio value
OCTAGON CAPITAL ADVISORS LP quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.10% | -80K shares | 54.15M | $68.3 | 2.50M |
| Q2 2022 | share | Increase | +10.38% | 243K shares | -2.09M | $45.22 | 2.58M |
| Q1 2022 | share | Increase | +15.79% | 319.14K shares | 23.34M | $50.81 | 2.34M |
| Q4 2021 | share | Increase | +26.63% | 425K shares | 42.94M | $47.95 | 2.02M |
| Q3 2021 | share | Increase | +27.04% | 339.64K shares | -26.79M | $32.96 | 1.59M |
| Q2 2021 | share | Increase | +129.09% | 707.89K shares | 55.86M | $63.2 | 1.25M |
| Q1 2021 | share | 0.00% | 0 shares | -7.83M | $42.91 | 548.37K | |
| Q4 2020 | share | Increase | 0.00% | 548.37K shares | 31.36M | $57.2 | 548.37K |